SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Robinson who wrote (91910)4/6/2000 7:48:00 AM
From: blackmerlin  Read Replies (1) of 120523
 
Biotech Rebound: At least 3 Biotech/Medtech stocks under $30/sh. have rebounded above their monthly close already
(see biobiznet.com). These are BCHE 22 5/8, BTGC 16, GENE 23 3/4. Many other bio/med stocks are edging up from Tuesday's big dip. This is a good sign.

Under $30 BioMed Index is now at 91% of it's monthly close (http://www.biobiznet.com).

The Long Run is Best-If we can resist selling on dips or cover margin calls from cash if we can, biotechs may pull through OK.
Regards,
Jake Blackmerlin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News